top of page
NemaLife YouTube Banner-2.png

NemaLife News

An amendment that will impact regulations for testing the safety & efficacy of drugs and ingredients

  • Writer: NemaLife
    NemaLife
  • Sep 30, 2022
  • 1 min read


Yesterday, the US Senate unanimously approved the FDA Modernization Act 2.0,

which was previously approved by the Lower House. This new bill which is expected to become a law soon aims to reduce testing with mammals, becoming a change accelerator for NemaLife, and increasing adoption of our cruelty-free platform.


This bill allows an applicant for market approval for a new drug to use methods other than animal testing to establish the drug's safety and effectiveness. Under this bill, these alternative methods may include cell-based assays, organ chips and microphysiological systems, sophisticated computer modeling, and other human biology-based test methods.


We invite companies in the foodtech, pharma, nutraceuticals, and microbiome space to reach out to us on how to obtain non-mammalian in vivo data and prepare for these changes in the regulatory landscape.



Comments


bottom of page